Dose-related statin myopathy: Is it an issue?

Article Type
Changed
Tue, 09/11/2018 - 09:09
Display Headline
Dose-related statin myopathy: Is it an issue?
Article PDF
Author and Disclosure Information

Robert L. Wortmann, MD
Professor and C.S. Lewis, Jr., MD, Chair of Medicine, The University of Oklahoma College of Medicine, Tulsa

Address: Robert L. Wortmann, MD, The University of Oklahoma College of Medicine, 4502 East 41st Street, Tulsa, OK 74135; e-mail robert-wortmann@ouhsc.edu

The author has indicated that he serves as a consultant to Merck and Company.

Issue
Cleveland Clinic Journal of Medicine - 72(9)
Publications
Topics
Page Number
751-753, 756
Sections
Author and Disclosure Information

Robert L. Wortmann, MD
Professor and C.S. Lewis, Jr., MD, Chair of Medicine, The University of Oklahoma College of Medicine, Tulsa

Address: Robert L. Wortmann, MD, The University of Oklahoma College of Medicine, 4502 East 41st Street, Tulsa, OK 74135; e-mail robert-wortmann@ouhsc.edu

The author has indicated that he serves as a consultant to Merck and Company.

Author and Disclosure Information

Robert L. Wortmann, MD
Professor and C.S. Lewis, Jr., MD, Chair of Medicine, The University of Oklahoma College of Medicine, Tulsa

Address: Robert L. Wortmann, MD, The University of Oklahoma College of Medicine, 4502 East 41st Street, Tulsa, OK 74135; e-mail robert-wortmann@ouhsc.edu

The author has indicated that he serves as a consultant to Merck and Company.

Article PDF
Article PDF
Related Articles
Issue
Cleveland Clinic Journal of Medicine - 72(9)
Issue
Cleveland Clinic Journal of Medicine - 72(9)
Page Number
751-753, 756
Page Number
751-753, 756
Publications
Publications
Topics
Article Type
Display Headline
Dose-related statin myopathy: Is it an issue?
Display Headline
Dose-related statin myopathy: Is it an issue?
Sections
Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media